Parallelised detection of bacteria viability using an electrode array and the Exeter Multiscope
Abstract Antimicrobial resistance remains a global existential threat. Given that antimicrobial therapy commonly starts before pathogen identification, rapid and scalable methods capable of determining effective antimicrobial compounds are needed. In this paper, we demonstrate a 2 × 2 array of parallelised microscopes that uses low numerical aperture (NA=0.25) detection optics and LED excitation to determine bacterial viability based on their fluorescence response to an electrical stimulus. Following a 2-hour incubation, the fluorescent viability readout requires less than one minute. We use K-means clustering to classify pixels in a time lapse sequence of widefield fluorescence images and extract changes seen within bacterial clusters. We demonstrate sufficient sensitivity to measure fluorescence changes after electrical stimulation in a bacterial monolayer. To capture these subtle fluorescence changes at high signal-to-background ratios, we place a limit on the minimum optical density of the bacterial sample. This novel approach is scalable to 96-well formats using a suitable consumable electrode array.
Authors
- Mike J. Shaw
- Ka Kiu Lee (ORCID: https://orcid.org/0000-0002-2061-3694)
- James P. Stratford (ORCID: https://orcid.org/0009-0001-0971-8313)
- Alexander D. Corbett (ORCID: https://orcid.org/0000-0003-1645-5475)
- D. W. Horsell (ORCID: https://orcid.org/0000-0001-7925-4035)
- Magdalena Karlikowska (ORCID: https://orcid.org/0000-0003-4996-0638)
- Junqing Jiang
- Salman Khattak
- Stefano Pagliara
- Tailise de-Souza-Guerreiro-Rodrigues
Institutions
- National Physical Laboratory (GB)
- University of Exeter (GB)
- The London College (GB)
- University College London (GB)
- Coventry University (GB)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-08-25
- DOI
- https://doi.org/10.1038/s41598-026-66381-9
- Primary Topic
- Bacterial biofilms and quorum sensing
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Joint Programming Initiative on Antimicrobial Resistance
- Government of the United Kingdom
- Medical Research Council
- Department for Science, Innovation and Technology